mounjaro tirzepatide 15 mg injection for Type 2 Diabetes Mounjaro

Food and Drug Administration (FDA) helps ensure the medicine remains safe, effective, and stable from the factory to the patients hands

Compounded drugs may vary in formulation, purity, or dosing compared with FDA-approved versions

Statistical analysis Considering the preliminary, descriptive nature of this study, a formal sample size calculation was not performed

It is often the result of chronic restriction, poor sleep, or hormonal imbalances

If you suspect your medication is causing side effects, you or your healthcare professional can report these through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or the Yellow Card app)

Kristensen SL, Rrth R, Jhund PS et al (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials